Publications by authors named "Hubert Hausmaninger"

Claim this Profile
D
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Michael A Fridrik, Hubert Hausmaninger, Alois Lang, Johannes Drach, Otto Krieger

Ann Hematol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Peter Dubsky, Paul Sevelda, Raimund Jakesz, Hubert Hausmaninger, Hellmut Samonigg

Clin Cancer Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
Michael F X Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, Stephan Grampp, Helmut Kaessmann, Hubert Hausmaninger

J Clin Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
David Nachbaur, Hildegard T Greinix, Elisabeth Koller, Otto Krieger, Werner Linkesch, Hubert Hausmaninger

Ann Hematol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of dose density therapy in patients with aggressive lymphoma.
Michael A Fridrik, Hubert Hausmaninger, Werner Linkesch, Richard Greil, Otto Krieger

Ann Hematol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.
Martin Filipits, Gudrun Pohl, Margaretha Rudas, Otto Dietze, Sigurd Lax, Hubert Hausmaninger

J Clin Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.
Peter Schmid, Walter Schippinger, Thorsten Nitsch, Gerdt Huebner, Volker Heilmann, Hubert Hausmaninger

J Clin Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.
Sebastian F Schoppmann, Guenther Bayer, Klaus Aumayr, Susanne Taucher, Silvana Geleff, Hubert Hausmaninger

Ann Surg· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.
Hubert Hausmaninger, Günter Morack, Bernhard Heinrich, Diethelm Wallwiener, Klaus Höffken

Am J Clin Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
Gudrun Pohl, Margaretha Rudas, Otto Dietze, Sigurd Lax, Eva Markis, Hubert Hausmaninger

J Clin Oncol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.
Raimund Jakesz, Hellmut Samonigg, Michael Gnant, Ernst Kubista, Dieter Depisch, Hubert Hausmaninger

Ann Surg· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
Marianne Schmid, Raimund Jakesz, Hellmut Samonigg, Ernst Kubista, Michael Gnant, Hubert Hausmaninger

J Clin Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
Raimund Jakesz, Hubert Hausmaninger, Ernst Kubista, Michael Gnant, Christian Menzel

J Clin Oncol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Monika Schindl, Sebastian F Schoppmann, Hellmut Samonigg, Hubert Hausmaninger, Werner Kwasny

Clin Cancer Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis